|
|
||||||||
Ann Thorac Surg 2002;74:1195-1200
© 2002 The Society of Thoracic Surgeons
a Division of Pediatric Cardiology, University of Michigan Medical Center, and Michigan Congenital Heart Center, Ann Arbor, Michigan, USA
b Division of Infection Control and Epidemiology, University of Michigan Medical Center, and Michigan Congenital Heart Center, Ann Arbor, Michigan, USA
c Division of Cardiac Surgery, University of Michigan Medical Center, and Michigan Congenital Heart Center, Ann Arbor, Michigan, USA
Accepted for publication June 13, 2002.
* Address reprint requests to Dr Maher, Department of Cardiology, Connecticut Childrens Medical Center, 282 Washington St, Hartford, CT, USA 06106.
e-mail: kmaher{at}nemours.org
BACKGROUND: Optimal antimicrobial prophylaxis for the pediatric cardiac surgical patient is unknown. We have reviewed our experience with more than 4,000 pediatric cardiac surgical patients at the University of Michigan to evaluate antibiotic prophylaxis regimens.
METHODS: Three antibiotic prophylaxis protocols were serially used during a 6-year period: Protocol 1 (n = 786): cefazolin was administered before operation and continued as long as thoracostomy tubes or central venous catheters were present; Protocol 2 (n = 1095): cefazolin was discontinued 48 hours postoperatively, regardless of the presence of tubes or catheters; Protocol 3 (n = 2039): cefazolin was continued as long as thoracostomy tubes were present, but not for central venous catheters. Patients with an open chest postoperatively received vancomycin and gentamicin until chest closure. This was identical during all three protocols. We retrospectively determined the rate of surgical site infections and unrelated bloodstream infections (the latter for both cardiac medical and surgical patients) for the three protocols.
RESULTS: Surgical site infections per 100 operations for protocols 1, 2, and 3 was 2.04, 6.58, and 1.67, respectively (p < 0.05 for protocol 2 versus protocols 1 and 3). The mean age of patients with a surgical site infection ranged from 12 to 15.4 months. Patients with an open chest had a higher rate of surgical site infection (18.8% for protocol 2 and 9.3% for protocol 3). Bloodstream infections per 1,000 patient days for protocols 1, 2, and 3 were 2.18, 6.51, and 5.02, respectively (p < 0.05 protocol 1 versus protocols 2 and 3).
CONCLUSIONS: These data suggest that pediatric cardiac surgical patients may benefit from prophylactic antibiotics as long as thoracostomy tubes are in place.
This article has been cited by other articles:
![]() |
C. A. Knoderer, E. G. Cox, M. D. Berg, A. H. Webster, and M. W. Turrentine Efficacy of limited cefuroxime prophylaxis in pediatric patients after cardiovascular surgery Am. J. Health Syst. Pharm., May 15, 2011; 68(10): 909 - 914. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Das, A. Rubio, J. M. Simsic, P. M. Kirshbom, B. Kogon, K. R. Kanter, and K. Maher Bloodstream Infections Increased After Delayed Sternal Closure: Cause or Coincidence Ann. Thorac. Surg., March 1, 2011; 91(3): 793 - 797. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. S. Woodward, M. Son, J. Calhoon, J. Michalek, and S. A. Husain Sternal Wound Infections in Pediatric Congenital Cardiac Surgery: A Survey of Incidence and Preventative Practice Ann. Thorac. Surg., March 1, 2011; 91(3): 799 - 804. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Costello, D. A. Graham, D. F. Morrow, J. Morrow, G. Potter-Bynoe, T. J. Sandora, F. A. Pigula, and P. C. Laussen Risk Factors for Surgical Site Infection After Cardiac Surgery in Children Ann. Thorac. Surg., June 1, 2010; 89(6): 1833 - 1842. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Knoderer, E. M. Anderson, and E. G. Cox Survey of congenital heart surgeons' preferences for antimicrobial prophylaxis for pediatric cardiac surgery patients Am. J. Health Syst. Pharm., November 1, 2008; 65(21): 2008 - 2010. [Full Text] [PDF] |
||||
![]() |
K. Dhadwal, S. Al-Ruzzeh, T. Athanasiou, M. Choudhury, P. Tekkis, P. Vuddamalay, H. Lyster, M. Amrani, and S. George Comparison of clinical and economic outcomes of two antibiotic prophylaxis regimens for sternal wound infection in high-risk patients following coronary artery bypass grafting surgery: a prospective randomised double-blind controlled trial Heart, September 1, 2007; 93(9): 1126 - 1133. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |